@growing_daniel The Chinese open-weight strategy is fascinating, and I agree I’m not sure it’ll work but the theory seems to be: 1) We have a much lower cost structure than the US labs, due to lower salaries, distillation, and (especially) PRC subsidies 2) We have second mover advantage
How is this a big win for Chinese labs if they’re open weights and never see the user data
